Wednesday 18 April 2012 - 11:15 - 11:30 - Grand Salon
Personalised Medicine, a cross-sectoral ambition
by Edvard Beem
The Netherlands are presently implementing a new top sector policy for research and innovation, based on a public-private partnership approach. Several of the nine topsectors deal with health and medicine, most prominently in Life Sciences and Health (LSH). LSH is structured around ten technological roadmaps, identified both by public knowledge institutions and private small, medium and large enterprises.
In the presentation it will be explained how personalised medicine as a concept can practically benefit from these roadmaps. By investing in LSH we invest in Europe as well, expecting to find the EC as a partner in a common enterprise.
Co-director The Netherlands Organisation of Health Research and Development from Netherlands
Dr Edvard Beem is co-director of the Netherlands Organisation of Health research and Development (ZonMw), holding the present position since the merger of ZON (health care innovation) and MW (medical and health sciences) in 2001.
Scientifically trained as biochemist he obtained his PhD in 1988 in Medicine, combining studies on the proteomics of lysosomal storage diseases (Free University of Amsterdam) with experimental chemotherapy of breast cancer (Netherlands Cancer Institute). Following the conduction of several postdoc projects he changed office in 1990 to finally become director of the Medical Research Council (MW) of the Netherlands Organisation of Scientific Research (NWO).
In his co-directorship of ZonMw special emphasis is given to strategic research development and international relations.